Literature DB >> 23163925

Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARα receptor-independent mechanism.

Ainhoa Bilbao1, Eduardo Blanco, María Jesús Luque-Rojas, Juan Suárez, Ana Palomino, Margarita Vida, Pedro Araos, Francisco J Bermúdez-Silva, Emilio Fernández-Espejo, Rainer Spanagel, Fernando Rodríguez de Fonseca.   

Abstract

Oleoylethanolamide (OEA) is an acylethanolamide that acts as an agonist of nuclear peroxisome proliferator-activated receptor alpha (PPARα) to exert their biological functions, which include the regulation of appetite and metabolism. Increasing evidence also suggests that OEA may participate in the control of reward-related behaviours. However, direct experimental evidence for the role of the OEA-PPARα receptor interaction in drug-mediated behaviours, such as cocaine-induced behavioural phenotypes, is lacking. The present study explored the role of OEA and its receptor PPARα on the psychomotor and rewarding responsiveness to cocaine using behavioural tests indicative of core components of addiction. We found that acute administration of OEA (1, 5 or 20 mg/kg, i.p.) reduced spontaneous locomotor activity and attenuated psychomotor activation induced by cocaine (20 mg/kg) in C57Bl/6 mice. However, PPARα receptor knockout mice showed normal sensitization, although OEA was capable of reducing behavioural sensitization with fewer efficacies. Furthermore, conditioned place preference and reinstatement to cocaine were intact in these mice. Our results indicate that PPARα receptor does not play a critical, if any, role in mediating short- and long-term psychomotor and rewarding responsiveness to cocaine. However, further research is needed for the identification of the targets of OEA for its inhibitory action on cocaine-mediated responses.
© 2012 The Authors, Addiction Biology © 2012 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163925     DOI: 10.1111/adb.12006

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  8 in total

1.  Role of the satiety factor oleoylethanolamide in alcoholism.

Authors:  Ainhoa Bilbao; Antonia Serrano; Andrea Cippitelli; Francisco J Pavón; Andrea Giuffrida; Juan Suárez; Nuria García-Marchena; Elena Baixeras; Raquel Gómez de Heras; Laura Orio; Francisco Alén; Roberto Ciccocioppo; Benjamin F Cravatt; Loren H Parsons; Daniele Piomelli; Fernando Rodríguez de Fonseca
Journal:  Addict Biol       Date:  2015-06-02       Impact factor: 4.280

2.  Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats.

Authors:  Aline Sayd; María Antón; Francisco Alén; Javier Rubén Caso; Javier Pavón; Juan Carlos Leza; Fernando Rodríguez de Fonseca; Borja García-Bueno; Laura Orio
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-28       Impact factor: 5.176

3.  Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum.

Authors:  Ana Palomino; Francisco-Javier Pavón; Eduardo Blanco-Calvo; Antonia Serrano; Sergio Arrabal; Patricia Rivera; Francisco Alén; Antonio Vargas; Ainhoa Bilbao; Leticia Rubio; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Front Integr Neurosci       Date:  2014-03-05

Review 4.  Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

Review 5.  An update on PPAR activation by cannabinoids.

Authors:  Saoirse Elizabeth O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-05-19       Impact factor: 8.739

6.  Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings.

Authors:  María Pedraz; Pedro Araos; Nuria García-Marchena; Antonia Serrano; Pablo Romero-Sanchiz; Juan Suárez; Estela Castilla-Ortega; Fermín Mayoral-Cleries; Juan Jesús Ruiz; Antoni Pastor; Vicente Barrios; Julie A Chowen; Jesús Argente; Marta Torrens; Rafael de la Torre; Fernando Rodríguez De Fonseca; Francisco Javier Pavón
Journal:  Front Psychiatry       Date:  2015-02-16       Impact factor: 4.157

7.  Moderate-vigorous physical activity across body mass index in females: moderating effect of endocannabinoids and temperament.

Authors:  Fernando Fernández-Aranda; Sarah Sauchelli; Antoni Pastor; Marcela L Gonzalez; Rafael de la Torre; Roser Granero; Susana Jiménez-Murcia; Rosa Baños; Cristina Botella; Jose M Fernández-Real; Jose C Fernández-García; Gema Frühbeck; Javier Gómez-Ambrosi; Roser Rodríguez; Francisco J Tinahones; Jon Arcelus; Ana B Fagundo; Zaida Agüera; Jordi Miró; Felipe F Casanueva
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

Review 8.  Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse.

Authors:  Laura Orio; Francisco Alen; Francisco Javier Pavón; Antonia Serrano; Borja García-Bueno
Journal:  Front Mol Neurosci       Date:  2019-01-09       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.